[1] 李华,杨英年.骨肉瘤动物模型的建立[J].中国组织工程研究, 2012,16(33): 6257-6261. [2] 于哲, 范清宇. 骨肉瘤动物模型的应用现状[J]. 现代肿瘤医学, 2006,14(1): 106-108.[3] 周光新,赵建宁.骨肉瘤动物模型构建的实验学特点[J]. 中国组织工程研究与临床康复, 2008, 12(37): 7374-7377.[4] Damstrup L,Rude Voldborg R,Spang-Thomsen M,et al. In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor. Br J Cancer. 1998; 78(5): 631-640. [5] Furukawa T, Fu X, Kubota T, et al. Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. Cancer Res. 1993;53(5):1204-1208. [6] Hillers KR, Dernell WS, Lafferty MH, et al. Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005;226(8):1364-1367.[7] Obata H, Kuratsu S, Uchida A,et al. Analysis of organ selectivity in the metastatic behavior of Dunn osteosarcoma. Clin Orthop Relat Res. 2002;(398):212-222. [8] Meyer WH, Houghton JA, Houghton PJ, et al. Development and characterization of pediatric osteosarcoma xenografts. Cancer Res. 1990;50(9):2781-2785.[9] 王子凡,梅炯骨肉瘤裸鼠移植瘤模型中的仿血管生成[J].同济大学学报:医学版,2008, 29(2): 7-10.[10] 屈小鹏,吴道澄,陈军,等.MDP2 阿霉素脂质体对裸鼠SOSP2M成骨肉瘤肺转移的治疗[J].第四军医大学学报, 2007, 28(24): 2232-2234.[11] 梅炯,窦帮,马晓辉,等.重组腺病毒介导小鼠内皮抑素对荷骨肉瘤 MG-63细胞裸鼠肺转移的抑制[J].中国肿瘤生物治疗杂志, 2008, 15(2):115-119.[12] 司海鹏,向理科,孙保勇,等.移植性骨肿瘤模型的生物学特性[J] .实用医学杂志,2003, 19(2):122-123.[13] 方挺松,许乙凯,黄信华,等.兔VX2骨肿瘤模型及综合影像评价[J] .临床放射学杂志, 2004 , 23(9):812-815.[14] 于哲,范清宇,张婷,等.大鼠骨肉瘤模型的建立[J] .动物医学进展, 2005, 26(2):58-60.[15] 彭磊,王臻,胡蕴玉,等.具有肺转移特性的人骨肉瘤细胞系PL-1的建立及其生物学特性观察[J].解放军医学杂志,2002,27(9): 805-807. [16] 杨宁,范清宇,殷剑宁,等.完整瘤组织块原位移植法建立人成骨肉瘤转移模型[J].癌症,2000,19(10): 843-846. [17] 龙华,范清宇,殷剑宁,等.高转移性人成骨肉瘤细胞系在裸小鼠体内的筛选和维持[J].细胞与分子免疫学杂志, 1999,15(1): 37-39. [18] 潘朝晖,范清宇,殷剑宁,等.人骨肉瘤自发性高肺转移模型的建立及其生物学特性初探[J].第四军医大学学报, 2000,21(4): 509-511.[19] Hillers KR, Dernell WS, Lafferty MH, et al.Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc. 2005;226(8):1364-1367.[20] 刘振峰,任晓强,艾力江•阿斯拉,等.细胞悬液注射法与组织块移植法建立骨肉瘤动物模型比较[J]. 科技导报,2013,31(16):65-68.[21] Luu H H, Kang Q, Park JK, et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clinical Experimental Metastasis, 2005; 22(4): 319-329.[22] Wang Y, Wang H. Functional genomics in drug target research. Chinese Pharmacological Bulletin. 2005; 21(3): 266-268.[23] Tinkey PT, Lembo TM, Evans GR, et al.Postirrasiation sarcomas inSprague-Dawley rats. Radiat Res.1998;149(4): 401-404.[24] Sakamoto A, Iwamoto Y. Current status and perspectivere-gardingthetreatment of osteosarcoma: chemotherapy. RevRecent ClinTrials.2008;3(3): 228-2311.[25] Bacci G, FerrariS, LariS, et al. Osteosarcomaof thelimb: am-putation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br.2002;84(1): 88-921.[26] Chiantore MV, Vannucchi S, Mangino G, et al.Senescence and cell death pathways and their role in cancer therapeutic outcome. Curr MedChem.2009;16(3): 287-3001.[27] 叶依依,刘胜,郭宝凤,等.蛇床子素配伍补骨脂素对人乳腺癌高骨转移细胞增殖及侵袭的影响[J].中华中医药学刊, 2013,31(1): 36-40.[28] Li D,Guo W,Tang X,et al.Preservation of the contralateral sacral nerves during hemisacrectomy for sacral malignancies. Eur Spine J.2014;23 (9):1933-1939.[29] Cieruik IF,Niemierko A,H armon DC,et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcom a. Cancer.2011;117(19):4522-4530.[30] DeLaney TF,Park L,Goldberg SI,et al.Radiotherapy for local control of osteosarcoma.Int J Radiat Oncol Biol Phys.2005; 61(2):492-498.[31] Li D,Guo W,Qu H,et al.Exper ience with wound eomplications after surgery for sacral tumors.Eur Spine J.2013;22(9): 2069-2076. |